Atlas Trials

Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency

Clinical trial NCT03667300 · COMPLETED

Trial details

NCT number
NCT03667300
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type2 Diabetes MellitusAlbuminuriaRenal Insufficiency
Start date
2017-03-16
Primary completion
2019-05-14
Enrollment
209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.